Bill McColl has 25+ years of experience as a senior producer and writer for TV, radio, and digital media leading teams of anchors, reporters, and editors in creating news broadcasts, covering some of ...
Both trials are ongoing and will report on overall survival at a subsequent analysis. Topline results were announced from two phase 3 trials evaluating combination regimens containing belzutifan ...
(RTTNews) - AbbVie's (ABBV) autoimmune drug Rinvoq has successfully met the endpoints in two replicate phase 3 studies in adult and adolescent patients with non-segmental vitiligo. Non-segmental ...
(RTTNews) - British drug major AstraZeneca PLC (AZN.L) Tuesday announced that MESSINA Phase III trial for Fasenra (benralizumab) failed to meet one of the two dual-primary endpoints in eosinophilic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback